Blue Biofuels (BIOF) Common Equity (2012 - 2025)

Blue Biofuels (BIOF) has 14 years of Common Equity data on file, last reported at -$3.7 million in Q4 2025.

• Common Equity for Q4 2025 came in at -$3.7 million, down 30.23% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.7 million (down 30.23% YoY), and the FY2025 annual result was -$3.7 million, down 30.23% from the prior year.
• Common Equity fell to -$3.7 million in Q4 2025 per BIOF's latest filing, from -$3.1 million in the prior quarter.
• Over five years, Common Equity peaked at -$299646.0 in Q1 2021 and troughed at -$4.8 million in Q2 2024.
• A 5-year average of -$2.6 million and a median of -$2.7 million in 2024 frame the typical range for Common Equity.
• The sharpest annual moves came in 2021 and 2022: Common Equity soared 91.22% in 2021, then plunged 581.45% in 2022.
• A 5-year view of Common Equity shows it stood at -$1.4 million in 2021, then tumbled by 68.83% to -$2.4 million in 2022, then plunged by 51.09% to -$3.6 million in 2023, then climbed by 20.08% to -$2.8 million in 2024, then plunged by 30.23% to -$3.7 million in 2025.
• Business Quant data shows BIOF's Common Equity at -$3.7 million in Q4 2025, -$3.1 million in Q3 2025, and -$3.2 million in Q2 2025.